MARKERS FOR THE DIAGNOSIS, MONITORING AND PROGNOSIS OF OSTEOPOROSIS AND FOR ASSESSING THE RISK FOR OSTEOPOROSIS AND FOR OSTEOPOROTIC FRACTURES

摘要

Use of biomarkers in the diagnosis, monitoring and prognosis of osteoporosis and also assessing the risk for osteoporosis and for osteoporotic fractures. A marker can include a chemokine, or a combination of chemokines. Specific chemokines include CXCL1, CXCL4, CXCL6 and CXCL8. Another biomarker can be CGRP that is CGRPα or CGRPβ, or combinations thereof.